LY3971297 Clinical Trials (2026): 2 Studies for Healthy & Heart Failure
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 LY3971297 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Healthy & Heart Failure) and 315 total planned enrollment. 1 LY3971297 clinical trial is actively recruiting. Most recent activity: NCT07547540 (Nov 2027).
LY3971297 clinical trials at a glance: phase × recruitment status
| Phase | active not recruiting | not yet recruiting | Total |
|---|---|---|---|
| P1 | 1 | 1 | 2 |
Recruiting LY3971297 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | P1 | Heart Failure | 90 | Aug 2026 |
LY3971297 clinical trials by indication
Heart Failure (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07547540 | — | P1 | not yet recruiting | A Study of LY3971297 in Participants With Heart Failure |
Healthy (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06148272 | — | P1 | active not recruiting | A Study of LY3971297 in Healthy Participants |
All LY3971297 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | P1 | not yet recruiting | 90 | Eli Lilly and Company | Aug 2026 | |
| NCT06148272 | A Study of LY3971297 in Healthy Participants | P1 | active not recruiting | 225 | Eli Lilly and Company | Dec 2023 |
LY3971297 clinical trials: frequently asked questions
- How many LY3971297 clinical trials are there?
- 2 LY3971297 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are LY3971297 clinical trials recruiting in 2026?
- No active LY3971297 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is LY3971297 being studied for?
- LY3971297 is being studied for Healthy, Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic, Hypertension and 1 more. The trials are grouped by indication on this page.
- What phase is LY3971297 in?
- LY3971297 clinical trials span 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY3971297 clinical trials?
- The lead sponsor across the most LY3971297 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY3971297as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: